Teleflex Incorporated (NYSE:TFX) Sees Significant Decrease in Short Interest

Teleflex Incorporated (NYSE:TFX) saw a significant drop in short interest during the month of January. As of January 31st, there was short interest totalling 638,200 shares, a drop of 15.6% from the January 15th total of 755,900 shares. Currently, 1.4% of the shares of the company are short sold. Based on an average daily volume of 228,600 shares, the days-to-cover ratio is currently 2.8 days.

Shares of TFX traded up $4.87 during trading hours on Friday, reaching $386.65. 175,200 shares of the stock traded hands, compared to its average volume of 174,110. The company has a current ratio of 2.33, a quick ratio of 1.44 and a debt-to-equity ratio of 0.72. Teleflex has a 52-week low of $269.88 and a 52-week high of $390.21. The company’s 50-day moving average price is $378.70 and its two-hundred day moving average price is $355.89. The company has a market cap of $17.44 billion, a P/E ratio of 41.05, a price-to-earnings-growth ratio of 2.07 and a beta of 0.94.

TFX has been the topic of several analyst reports. Morgan Stanley lifted their price target on shares of Teleflex from $392.00 to $405.00 and gave the stock an “overweight” rating in a research note on Tuesday, December 17th. Wells Fargo & Co lifted their price target on shares of Teleflex from $415.00 to $425.00 and gave the stock an “overweight” rating in a research note on Friday, January 17th. Needham & Company LLC lifted their price target on shares of Teleflex from $408.00 to $423.00 and gave the stock a “buy” rating in a research note on Friday, January 31st. Barclays set a $365.00 price target on shares of Teleflex and gave the stock a “hold” rating in a research note on Friday, November 1st. Finally, UBS Group lifted their price target on shares of Teleflex from $415.00 to $430.00 and gave the stock a “buy” rating in a research note on Wednesday, December 18th. Three analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $400.60.

In other news, CFO Thomas E. Powell sold 5,000 shares of Teleflex stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $348.70, for a total transaction of $1,743,500.00. Following the transaction, the chief financial officer now owns 15,697 shares in the company, valued at approximately $5,473,543.90. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Stephen K. M.D. Klasko sold 200 shares of Teleflex stock in a transaction on Monday, November 25th. The stock was sold at an average price of $346.63, for a total transaction of $69,326.00. Following the transaction, the director now owns 936 shares in the company, valued at approximately $324,445.68. The disclosure for this sale can be found here. Insiders sold 6,700 shares of company stock worth $2,342,968 in the last 90 days. 2.36% of the stock is currently owned by corporate insiders.

Several institutional investors and hedge funds have recently added to or reduced their stakes in TFX. Parkside Financial Bank & Trust lifted its stake in shares of Teleflex by 85.4% during the 4th quarter. Parkside Financial Bank & Trust now owns 76 shares of the medical technology company’s stock valued at $29,000 after buying an additional 35 shares in the last quarter. Atlas Capital Advisors LLC purchased a new position in shares of Teleflex during the 3rd quarter valued at $39,000. Emerald Advisers LLC purchased a new position in shares of Teleflex during the 4th quarter valued at $56,000. Sowell Financial Services LLC lifted its stake in shares of Teleflex by 362.2% during the 4th quarter. Sowell Financial Services LLC now owns 171 shares of the medical technology company’s stock valued at $64,000 after buying an additional 134 shares in the last quarter. Finally, CSat Investment Advisory L.P. lifted its stake in shares of Teleflex by 19.1% during the 4th quarter. CSat Investment Advisory L.P. now owns 193 shares of the medical technology company’s stock valued at $73,000 after buying an additional 31 shares in the last quarter. Institutional investors own 90.73% of the company’s stock.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It offers vascular access products that comprise Arrow branded catheters and related devices, including catheter positioning systems for use in the administration of intravenous medications and other therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site; and devices for treating coronary and peripheral vascular disease.

Featured Story: Most Active Stocks: Dollar Volume vs Share Volume

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.